Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
AssigneeBristol-Myers Squibb Company
InventorsYaofeng Cheng, Weiqi Chen, Brad D. Maxwell, Bach D. Tran, Jun Li
Life of this patent
Estimating the term…
Abstract
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein R* is an isotopically labeled hydroxypropyl moiety.
Claims15
A compound, enantiomer, diastereomer, or salt thereof, of a compound of formula I:
- wherein R* is an isotopically labeled hydroxypropyl moiety.
A compound, enantiomer, diastereomer, or salt thereof, of a compound of formula II:
Dependencies are inferred from the claim text.